HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy

While human epidermal growth factor receptor 2 (HER2) aberrations have long been described in patients with non-small cell lung cancer (NSCLC), they have only recently been effectively targeted. Unlike patients with breast cancer, NSCLC patients can harbor either HER2-activating mutations or HER2 am...

Descripción completa

Detalles Bibliográficos
Autores principales: Vathiotis, Ioannis A., Charpidou, Andriani, Gavrielatou, Niki, Syrigos, Konstantinos N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705364/
https://www.ncbi.nlm.nih.gov/pubmed/34959700
http://dx.doi.org/10.3390/ph14121300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705364/
https://www.ncbi.nlm.nih.gov/pubmed/34959700
http://dx.doi.org/10.3390/ph14121300

Ejemplares similares